Ecstasy - MDMA and other ring-substituted amphetamines
31 December 2000
| Publication
Overview
Given the sustained high level of interest in ecstasy and recent findings relating to neurotoxicity, it was considered timely to undertake a specific review of the health effects of ecstasy. The primary focus of this review is 3,4-methylenedioxymethamphetamine (MDMA). However, some consideration is given to structurally related ring-substituted amphetamines, particularly those that are used or sold as ecstasy, either intentionally or through manufacturing errors.
WHO Team
Alcohol, Drugs and Addictive Behaviors
Editors
World Health Organization
Number of pages
96
Reference numbers
WHO Reference Number: WHO/MSD/MSB/01.3
Copyright
World Health Organization